Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Burning Rock of Guangzhou Plans $100 Million IPO on NASDAQ

publication date: May 26, 2020

Burning Rock Biotech, a Guangzhou diagnostics company, filed for a NASDAQ IPO to support its precision medicine and early cancer detection business. Founded in 2014, Burning Rock claims to be China’s leading NGS-based cancer therapy selection company with a market share of 27% in 2019. The company offers in-hospital testing in larger institutions and central laboratory testing services to smaller hospitals. Currently, Burning Rock offers 13 NGS-based cancer therapy selection tests for a broad range of cancer types, using tissue or liquid biopsy samples. The company is seeking to raise up to $100 million in the offering. More details....

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital